title: Chronic administration of nimodipine and propranolol in elderly normotensive subjects--an interaction study.
abstract: Nimodipine (30 mg t.i.d.) and propranolol (40 mg t.i.d.) were given orally to 24 healthy elderly subjects in a randomized, un-blinded, threefold crossover study. Each of the study periods lasted 8 days with a 5-day treatment phase separated by 2-week washout phases. Mean peak nimodipine plasma concentration was decreased after combined administration of the two drugs (16.1 +/- 8.1 micrograms/l vs. 12.4 +/- 9.5 micrograms/l). Nimodipine AUCss slightly decreased under propranolol co-medication from 44.9 +/- 15.1 micrograms x l/l to 38.8 +/- 22.5 micrograms x h/l, resulting in an AUC ratio of 88.8 +/- 44.5%. The relative bioavailability of propranolol was 104.1 +/- 38.3% after the combined propranolol and nimodipine medication, all other pharmacokinetic parameters remained unchanged. The pharmacological effects on the cardiovascular system were negligible after nimodipine alone. The reductions in blood pressure and pulse rate and the prolongations of typical ECG times observed after propranolol monotherapy and after the combination therapy were of similar size and were almost solely attributed to the action of the beta-blocker. The findings of this study indicate that chronic treatment with nimodipine together with propranolol should not be associated with a clinically relevant interaction.
authors.affiliation: AFB Klinische Pharmakologie GmbH, Berlin, Germany.
authors.forename: H P
authors.initials: HP
authors.lastname: Breuel
authors.forename: P R
authors.initials: PR
authors.lastname: Heine
authors.forename: W
authors.initials: W
authors.lastname: Mück
authors.forename: H
authors.initials: H
authors.lastname: Niklaus
authors.forename: N
authors.initials: N
authors.lastname: Schmage
authors.forename: J
authors.initials: J
authors.lastname: Kuhlmann
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001682:Biological Availability; D001794:Blood Pressure / Q000187:drug effects; D018592:Cross-Over Studies; D004347:Drug Interactions; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009553:Nimodipine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D011433:Propranolol / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D011674:Pulse / Q000187:drug effects
chemical_list: D009553:Nimodipine; D011433:Propranolol